Leptin and leptin receptor expression as biomarkers for breast cancer: a retrospective study

Abstract

Abstract Background Effective screening and treatment have reduced the number of women dying from breast cancer (BC). However, the long-term sequelae of BC treatment and psychosocial factors seriously affect the life quality of BC patients and survivors. Therefore, the discovery and application of targeted biomarkers to improve the functional outcome and life quality of BC patients is necessary. Aims To explore the impact of leptin (LEP)/ leptin receptor (LEPR) expression on occurrence and survival of BC. Methods Totally 132 primary BC and 66 non-BC patients who underwent surgery in department of breast surgery in Shanxi Cancer Hospital from January to October in 2009 were enrolled in this retrospective study. LEP and LEPR were examined in BC tissues, benign breast tissues, para-carcinoma tissues using immunohistochemical staining. Kaplan–Meier curve was generated to test survival time. Results The high level expression of LEP and LEPR in BC tissues were significantly higher than that in benign breast tissues and in para-carcinoma tissues (all P 0.05). Conclusions High LEP/LEPR expression were risk factors for occurrence of BC, but without impact on survival.

Keywords

• Breast cancer
• Leptin
• Leptin receptor
• Survival